Urolithin A recharges aging immune cells and boosts mitochondrial fitness in midlife adults
View as a Web Page
News Medical
 
  Hematology Hematology logo  
  The latest hematology news from News Medical  
 Amla (Indian Gooseberry) health benefits: From vitamin C to anti-aging evidenceAmla (Indian Gooseberry) health benefits: From vitamin C to anti-aging evidence
 
From lab bench to clinic, discover how a centuries-old superfruit translates into measurable gains in glycemic control, lipid profiles, skin health, and resilience against oxidative stress.
 
 
 Urolithin A recharges aging immune cells and boosts mitochondrial fitness in midlife adultsUrolithin A recharges aging immune cells and boosts mitochondrial fitness in midlife adults
 
Urolithin A, a natural postbiotic known to trigger mitophagy, rejuvenated key immune cell functions in healthy middle-aged adults after 28 days. The trial showed a shift toward a youthful, energy-efficient CD8⁺ T-cell profile and enhanced bacterial clearance without inflammatory side effects.
 
   Children face greater heart and inflammatory risks after COVID-19 infection than vaccinationChildren face greater heart and inflammatory risks after COVID-19 infection than vaccination
 
The study is the largest of its kind in this population, and is published in The Lancet Child and Adolescent Health.
 
   How walnuts combat inflammation and oxidative stress in the bodyHow walnuts combat inflammation and oxidative stress in the body
 
This review in Food Science & Nutrition synthesizes evidence showing that walnuts (Juglans regia L.) exert potent antioxidant, anti-inflammatory, apoptosis-regulatory, and immunomodulatory effects through bioactive compounds influencing mitochondrial, cytokine, and redox pathways.
 
   Eating peanuts while pregnant may influence how a child’s genes respond to breastfeedingEating peanuts while pregnant may influence how a child’s genes respond to breastfeeding
 
Maternal peanut and peanut butter consumption during pregnancy and breastfeeding shaped DNA methylation patterns in children, particularly in genes regulating neurodevelopment and inflammation. These findings suggest maternal diet can prime offspring epigenetic sensitivity to breastfeeding duration.
 
 Dysfunction in chromosome-stabilizing protein identified as a cause of deadly illnesses
 
Dysfunction in chromosome-stabilizing protein identified as a cause of deadly illnessesNew research from the University of Wisconsin–Madison reveals that dysfunction in a protein essential to maintaining stability in our chromosomes may be responsible for serious - and sometimes deadly - diseases.
 
 
 Bacterial extracellular vesicles and their role in PCOS and endometriosis explained
 
Bacterial extracellular vesicles and their role in PCOS and endometriosis explainedBEVs carry diverse molecular cargo that offers non-invasive biomarkers for early diagnosis and monitoring of PCOS and endometriosis.
 
 
 Alzheimer’s breakthrough reveals how tweaking one gene shields brain connections
 
Alzheimer’s breakthrough reveals how tweaking one gene shields brain connectionsLowering the transcription factor PU.1 reprograms microglia into a neuroprotective, lymphoid-like state that compacts amyloid, blocks tau spread, and preserves synapses in Alzheimer’s disease. Microglial CD28 signaling helps restrain inflammation, revealing a regulatory switch that may inform future immunotherapies targeting microglia rather than neurons.
 
 
 Combination therapy offers hope for ending lifelong chronic lymphocytic leukemia treatment
 
Combination therapy offers hope for ending lifelong chronic lymphocytic leukemia treatmentIanalumab targets the B-cell activating factor receptor (BAFR) and ibrutinib belongs to a class of therapeutics called Bruton's tyrosine kinase inhibitors (BTKi).
 
 
 Rapamycin shows promise in treating cold tumors with specific gene mutation
 
Rapamycin shows promise in treating cold tumors with specific gene mutationImmune checkpoint inhibitors (ICIs) emerged in the US about 15 years ago as an exciting class of cancer treatments that have achieved complete and durable remissions for thousands of people with end-stage metastatic cancers.
 
 
 New genetic marker may improve the ability to predict life-threatening reactions to gout medication
 
New genetic marker may improve the ability to predict life-threatening reactions to gout medicationA newly identified genetic marker may significantly improve the ability to predict life-threatening reactions to the gout medication allopurinol in U.S. patients.
 
 
 Trojan horse strategy using cesium nanosalts shows powerful anti-cancer effects
 
Trojan horse strategy using cesium nanosalts shows powerful anti-cancer effectsRecently, a team led by Academician Hongjie Zhang, Researcher Shuyan Song, Associate Researcher Pengpeng Lei, and Dr. Ran An at the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, developed an innovative strategy to construct a series of biodegradable cesium nanosalts.
 
 
 Research shows the potential of structural nanomedicine in cancer treatment
 
Research shows the potential of structural nanomedicine in cancer treatmentIn a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic.
 
 
 Advances in diagnosis and management of systemic light chain amyloidosis
 
Advances in diagnosis and management of systemic light chain amyloidosisSystemic light chain (AL) amyloidosis is a rare and life-threatening disorder characterized by the deposition of misfolded immunoglobulin light chains as insoluble amyloid fibrils in various tissues and organs, leading to progressive structural and functional impairment.
 
 
 Sirolimus-eluting balloon strategy matches drug-eluting stents in large international PCI trial
 
Sirolimus-eluting balloon strategy matches drug-eluting stents in large international PCI trialNew study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates found that utilizing a strategy of sirolimus-eluting balloons with bailout stenting only if necessary was noninferior to routine drug-eluting stent (DES) implantation as part of the treatment for de novo coronary artery disease.
 
 
 St. Jude scientists identify new therapeutic target for high-risk pediatric leukemia
 
St. Jude scientists identify new therapeutic target for high-risk pediatric leukemiaAcute myeloid leukemia driven by tandem duplications within the UBTF gene (UBTF-TD AML) is a high-risk pediatric cancer in urgent need of novel therapeutic options.
 
 
 Hidden cell structures reveal a common weakness in leukemia
 
Hidden cell structures reveal a common weakness in leukemiaA hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like disorder turned out to follow a simple physical rule – one that connects several major mutations behind the disease.
 
 
 Multiple protein forms from a single gene offer fresh insight into rare disease mechanisms
 
Multiple protein forms from a single gene offer fresh insight into rare disease mechanismsIain Cheeseman and colleagues reveal the underappreciated role of single genes producing multiple proteins in atypical presentations of rare disease, and present case studies of affected patients through a collaboration with Boston Children's Hospital.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025